Follow-The-Filings

Security

Cullinan Oncology Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 1 exit max 0.0% (Steve Cohen - Point72 Ass...)

owners 8
max % 0.0%
tracked value $85M
qoq A 5 R 2 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Add +0.01 pp 905,376 $13M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add +0.01 pp 1,049,581 $15M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit -0.01 pp 470,526 $5M hist
Renaissance Technologies LLC 2026 Q1 0.0% Reduce 0.00 pp 324,111 $5M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 3,298,504 $34M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 360,874 $5M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 346,582 $5M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 252,778 $4M hist
D. E. Shaw & Co., Inc. exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 14,365 $149 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$153.16M -$167.38M -$219.88M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $480.19M $414.67M $386.76M
Total non-current assets * $3.99M $207.16M $61.62M
Total assets $484.18M $621.82M $448.37M
Total current liabilities $28.14M $30.65M $37.74M
Total non-current liabilities * $2.15M $849,000 $1.9M
Total equity $453.7M $590.33M $408.73M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$134.28M -$145.3M -$175.75M
Cash from investing $35.81M -$136.31M $179.99M
Cash from financing $40.75M $266.19M $1.09M
Net change in cash * -$57.72M -$15.43M $5.33M

ownership over time

filing count by report period · click a bar for that quarter’s holders